WallStSmart
TNDM

Tandem Diabetes Care Inc

NASDAQ: TNDM · HEALTHCARE · MEDICAL DEVICES

$18.16
-2.52% today

Updated 2026-04-29

Market cap
$1.24B
P/E ratio
P/S ratio
1.23x
EPS (TTM)
$-3.04
Dividend yield
52W range
$10 – $30
Volume
2.3M

Tandem Diabetes Care Inc (TNDM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-3.1%
Last 4 quarters
Revenue YoY growth
+2.7%
Most recent quarter
EPS YoY growth
+97.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+5.5%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+29.7%
2026-02-19
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-19$-0.01+89.1%$18.94$24.57+29.7%
2025-11-06$-0.31+3.1%$14.67$16.26+10.8%
2025-08-06$-0.78-95.0%$15.15$11.52-24.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.09$-0.01+89.1%$290.38M+2.7%
2025-09-30$-0.32$-0.31+3.1%$249.25M-31.4%
2025-06-30$-0.40$-0.78-95.0%$240.68M+8.5%
2025-03-31$-0.61$-0.67-9.5%$234.42M+22.3%
2024-12-31$-0.24$-0.44-84.8%$282.65M+43.6%
2024-09-30$-0.40$-0.35+12.5%$363.29M+95.7%
2024-06-30$-0.54$-0.48+11.1%$221.91M+13.3%
2024-03-31$-0.76$-0.63+17.1%$191.67M
2023-12-31$-0.25$-0.27-8.0%$196.80M
2023-09-30$-0.34$-0.38-11.8%$185.62M
2023-06-30$-0.53$-0.55-3.8%$195.92M

Frequently asked questions

Has Tandem Diabetes Care Inc beaten earnings estimates?
Tandem Diabetes Care Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -3.1% over the last 4 quarters.
How does TNDM stock react to earnings?
TNDM stock has moved an average of +5.5% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Tandem Diabetes Care Inc's revenue growth rate?
Tandem Diabetes Care Inc reported year-over-year revenue growth of +2.7% in its most recent quarter, with EPS growing +97.7% year-over-year.